APA (7th ed.) Citation

DD, S., BK, B., KM, Y., J, J., R, K., U, S., & DI, B. (2016). Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer. The oncologist, 21(2), 196. https://doi.org/10.1634/theoncologist.2015-0162

Chicago Style (17th ed.) Citation

DD, Stenehjem, Bellows BK, Yager KM, Jones J, Kaldate R, Siebert U, and Brixner DI. "Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer." The Oncologist 21, no. 2 (2016): 196. https://doi.org/10.1634/theoncologist.2015-0162.

MLA (9th ed.) Citation

DD, Stenehjem, et al. "Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer." The Oncologist, vol. 21, no. 2, 2016, p. 196, https://doi.org/10.1634/theoncologist.2015-0162.